Professional
Added to YB: 2024-06-20
Pitch date: 2024-03-31
RHHBY [bullish]
Roche Holding AG
+57.74%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
Market Cap
CHF 240.6B
Pitch Price
CHF 31.72
Price Target
N/A
Dividend
3.46%
EV/EBITDA
11.29
P/E
23.88
EV/Sales
4.21
Sector
Pharmaceuticals
Category
growth
Show full summary:
Mairs & Power Growth Fund Portfolio Holding: Roche Holding AG
RHHBY: World's largest biotech partnering with NVDA to use AI to accelerate drug development from decade+ to much shorter. Recent setbacks, but robust pipeline of promising biologics. Investment case not contingent on AI, but RHHBY should lead if AI drug development breakthrough occurs.
Read full article (1 min)